<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chung JO</submitter><funding>NICHD NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>U.S. Public Health Service</funding><pagination>2082-2091</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5521869</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>66(8)</volume><pubmed_abstract>We investigated the relationship between insulin resistance markers and subsarcolemmal (SS) and intramyofibrillar (IMF) ceramide concentrations, as well as the contribution of plasma palmitate (6.5-h infusion of [U-&lt;sup>13&lt;/sup>C]palmitate) to intramyocellular ceramides. Seventy-six postabsorptive men and women had muscle biopsies 1.5, 6.5, and 24 h after starting the tracer infusion. Concentrations and enrichment of muscle ceramides were measured by liquid chromatography-tandem mass spectrometry. We found that HOMA of insulin resistance, plasma insulin, and triglyceride concentrations were positively correlated with SS C16:0 and C18:1 ceramide, but not SS C14:0-Cer, C20:0-Cer, C24:0-Cer, and C24:1-Cer concentrations; IMF ceramide concentrations were not correlated with any metabolic param</pubmed_abstract><journal>Diabetes</journal><pubmed_title>Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.</pubmed_title><pmcid>PMC5521869</pmcid><funding_grant_id>R-00585</funding_grant_id><funding_grant_id>R01 DK045343</funding_grant_id><funding_grant_id>T32 DK007352</funding_grant_id><funding_grant_id>P30 DK050456</funding_grant_id><funding_grant_id>K12 HD065987</funding_grant_id><funding_grant_id>DK-45343</funding_grant_id><funding_grant_id>DK-50456</funding_grant_id><funding_grant_id>M01 RR000585</funding_grant_id><funding_grant_id>R01 DK040484</funding_grant_id><funding_grant_id>R37 DK040484</funding_grant_id><funding_grant_id>DK-40484</funding_grant_id><pubmed_authors>Hames KC</pubmed_authors><pubmed_authors>Blachnio-Zabielska AU</pubmed_authors><pubmed_authors>Jensen MD</pubmed_authors><pubmed_authors>Chung JO</pubmed_authors><pubmed_authors>Koutsari C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.</name><description>We investigated the relationship between insulin resistance markers and subsarcolemmal (SS) and intramyofibrillar (IMF) ceramide concentrations, as well as the contribution of plasma palmitate (6.5-h infusion of [U-&lt;sup>13&lt;/sup>C]palmitate) to intramyocellular ceramides. Seventy-six postabsorptive men and women had muscle biopsies 1.5, 6.5, and 24 h after starting the tracer infusion. Concentrations and enrichment of muscle ceramides were measured by liquid chromatography-tandem mass spectrometry. We found that HOMA of insulin resistance, plasma insulin, and triglyceride concentrations were positively correlated with SS C16:0 and C18:1 ceramide, but not SS C14:0-Cer, C20:0-Cer, C24:0-Cer, and C24:1-Cer concentrations; IMF ceramide concentrations were not correlated with any metabolic param</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2025-04-04T20:54:32.965Z</modification><creation>2019-03-26T23:48:32Z</creation></dates><accession>S-EPMC5521869</accession><cross_references><pubmed>28483801</pubmed><doi>10.2337/db17-0082</doi></cross_references></HashMap>